Role of next generation sequencing-based liquid biopsy in advanced non-small cell lung cancer patients treated with immune checkpoint inhibitors: impact of STK11, KRAS and TP53 mutations and co-mutations on outcome
2020 ◽
Vol 21
(5)
◽
pp. e497-e510
◽
2016 ◽
2017 ◽
2017 ◽
Vol 9
(S13)
◽
pp. S1383-S1390
◽